Td Asset Management Inc Madrigal Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

  • $114 Billion
  • Q3 2025

A detailed history of Td Asset Management Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 13,324 shares of MDGL stock, worth $7.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,324
Previous 23,240 42.67%
Holding current value
$7.05 Million
Previous $7.03 Million 13.11%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
SELL
$287.52 - $458.66 $2.85 Million - $4.55 Million
-9,916 Reduced 42.67%
13,324 $6.11 Million
Q2 2025

Jul 28, 2025
BUY
$267.56 - $340.8 $267,560 - $340,800
1,000 Added 4.5%
23,240 $7.03 Million
Q1 2025

May 07, 2025
SELL
$272.79 - $355.88 $1.12 Million - $1.46 Million
-4,090 Reduced 15.53%
22,240 $7.37 Million
Q4 2024

Feb 11, 2025
SELL
$202.45 - $354.85 $2.39 Million - $4.19 Million
-11,800 Reduced 30.95%
26,330 $8.12 Million
Q3 2024

Nov 01, 2024
SELL
$212.22 - $292.96 $3.74 Million - $5.16 Million
-17,600 Reduced 31.58%
38,130 $8.09 Million
Q2 2024

Aug 02, 2024
BUY
$193.33 - $291.99 $1.04 Million - $1.58 Million
5,400 Added 10.73%
55,730 $15.6 Million
Q1 2024

May 08, 2024
BUY
$171.37 - $283.23 $5.96 Million - $9.85 Million
34,790 Added 223.87%
50,330 $13.4 Million
Q4 2023

Feb 12, 2024
BUY
$120.4 - $237.13 $1.87 Million - $3.69 Million
15,540 New
15,540 $3.6 Million
Q1 2021

May 14, 2021
SELL
$108.54 - $125.2 $520,992 - $600,960
-4,800 Closed
0 $0
Q3 2020

Nov 10, 2020
BUY
$99.78 - $124.21 $159,149 - $198,114
1,595 Added 49.77%
4,800 $570,000
Q2 2020

Aug 13, 2020
BUY
$60.13 - $125.71 $192,716 - $402,900
3,205 New
3,205 $363,000
Q3 2019

Nov 07, 2019
SELL
$84.4 - $106.53 $505,387 - $637,901
-5,988 Closed
0 $0
Q2 2019

Aug 01, 2019
BUY
$91.13 - $142.5 $9,113 - $14,250
100 Added 1.7%
5,988 $628,000
Q1 2019

May 08, 2019
SELL
$103.48 - $143.84 $62,088 - $86,304
-600 Reduced 9.25%
5,888 $738,000
Q4 2018

Feb 01, 2019
SELL
$94.77 - $215.54 $654,292 - $1.49 Million
-6,904 Reduced 51.55%
6,488 $731,000
Q3 2018

Nov 01, 2018
SELL
$207.3 - $300.31 $706,478 - $1.02 Million
-3,408 Reduced 20.29%
13,392 $2.87 Million
Q2 2018

Jul 31, 2018
BUY
$101.55 - $313.9 $873,330 - $2.7 Million
8,600 Added 104.88%
16,800 $4.7 Million
Q1 2018

May 11, 2018
BUY
$93.35 - $149.04 $765,470 - $1.22 Million
8,200 New
8,200 $958,000

Others Institutions Holding MDGL

# of Institutions
405
Shares Held
23.1M
Call Options Held
665K
Put Options Held
514K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $9.05B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email